Promino Nutritional Sciences reported a significant improvement in its 2025 financial results, with revenue rising to over $2.1 million from about $260,600 in 2024, and net loss shrinking from $7.1 million to $3.0 million. The company expanded distribution of its core product, Rejuvenate Muscle Health™, supported by growth in e-commerce and retail channels. Cost management efforts reduced expenses to $3.4 million from $6.3 million the previous year. Promino also enhanced its financial reporting and governance after lifting a cease-trade order and initiated a large production run to meet anticipated demand. These steps position the company for disciplined growth and operational strengthening in the muscle health nutrition market.
Taco Bell Canada introduced two new menu items: Crispy Chicken Nuggets with a Jalapeño Honey Mustard sauce, and Mountain Dew Baja Midnight, the first new Mountain Dew Baja Blast flavor in over 20 years. The nuggets feature all-white meat with Mexican...
VERAXA Biotech updated on its progress in developing novel cancer therapies using its proprietary BiTAC platform, focusing on conditionally active T cell engagers and bispecific antibody-drug conjugates. The company plans to prioritize investment in ...
Nexans and Hydro have agreed on a five-year contract for about 85,000 tonnes of low-carbon aluminium wire rod to support Europe's electricity grid modernization. This aluminium, produced using 100% renewable energy in Norway, will help reduce carbon ...
Nexans and Hydro have agreed on a five-year supply contract for about 85,000 tons of low-carbon aluminum wire rod to support the modernization and decarbonization of Europe's electrical grid. The aluminum, produced in Norway using 100% renewable ener...
Scilex Holding Company announced a binding term sheet with Kazakhstan-based iHolding Group LLP for a $100 million investment, purchasing about 6.67 million shares at $15 each. This funding aims to support Scilex's strategic growth in healthcare, prod...
